← All organizations
Highest phase reached
Phase 3
First clinical trial
Feb 18, 2021Last known activity
Dec 31, 2025
Timeline
2010s
- Jun 1, 2019
NewAmsterdam Pharma— Founded
Drugs by trial phase (6 distinct, 17 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Recent trials (24)
- NCT07219602Lead sponsorPhase 3Dec 31, 2025
- NCT06982508Lead sponsorPhase 2Sep 9, 2025
- NCT06547359Lead sponsorPhase 1Oct 1, 2024
- NCT06496243Lead sponsorPhase 2Aug 31, 2024
- NCT06305559Lead sponsorPhase 3May 16, 2024
- NCT06005597Lead sponsorPhase 3Jan 31, 2024
- NCT06005597Study directorPhase 3Jan 31, 2024
- NCT06081166Lead sponsorPhase 1Oct 31, 2023
- NCT06048302Lead sponsorPhase 1Oct 25, 2023
- NCT05972278Lead sponsorPhase 1Sep 25, 2023
- NCT05425745Study directorPhase 3Jul 25, 2022
- NCT05425745Lead sponsorPhase 3Jul 25, 2022
- NCT05421078Lead sponsorPhase 2Jun 27, 2022
- NCT05421078Study directorPhase 2Jun 27, 2022
- NCT05266586Lead sponsorPhase 2Mar 9, 2022
Details
- Founded
- Amsterdam, NL Jun 1, 2019
- Last known activity
- Dec 31, 2025